What's missing: No human pharmacokinetic data No human safety data No optimal dose for humans (mouse 20mg/kg = ~150mg in a 75kg human if dose-equivalent, but mouse-to-human scaling for small molecules is unreliable) No drug interaction data No long-term safety data Buyers in this category are doing biohacker-tier self-experimentation with limited data
"By selling Tirzepatide ODT, Empower is essentially conducting a mass testing experiment on consumers." In a statement to Houston Public Media, a spokesperson for Empower Pharmacy said the company does not produce copies of Eli Lillys drugs and does not violate any federal or state laws
That means some things may not work as well, or may start building up in ways you dont expect
For bulk purchases where you are committing significant capital, third-party verification is not paranoia
Monitoring During the Switch: Close communication and follow-up appointments with the healthcare provider are necessary during the transition
Deploying resources that explain the value of good sleep hygiene and its effect on reducing fatigue can be instrumental